SARS-CoV-2 exploits cellular RAD51 to promote viral propagation: implication of RAD51 inhibitor as a potential drug candidate against COVID-19.
Pham TX, Huynh TTX, Choi J, Lee J-B, Park S-C, Kim B, Lim Y-S, Hwang SB. J Virol. 2023 Dec 21; 97(12):e0173723. Epub 2023 Dec 5.